Know all about the effects of ruxolitinib/ruxolitinib cream, a new choice for treating skin diseases!

Ruxolitinib/ruxolitinib cream (ruxolitinib) is a topical treatment drug that has received widespread attention in recent years, especially in the treatment of immune skin diseases such as atopic dermatitis/eczema (AD) and vitiligo. As a selective JAK inhibitor, ruxolitinib can effectively regulate abnormal responses of the immune system, thereby reducing skin inflammation caused by excessive immune activation. Research and clinical application of ruxolitinib cream are gradually unfolding around the world, especially in the field of treating skin diseases, where it provides patients with new treatment options.

Ruxolitinib cream can directly act on the immune response on the skin surface by inhibiting theJAK-STAT signaling pathway. The JAK-STAT pathway plays a central role in cellular immune responses, especially the generation of inflammation and the activation of immune cells. By blocking this signaling pathway, ruxolitinib can reduce the excessive response of immune cells and relieve the skin's inflammatory response. Unlike traditional immunosuppressive drugs, the topical application of ruxolitinib cream has lower systemic side effects. It can act directly on the affected area without causing extensive immunosuppression through systemic circulation like oral drugs.

Clinical studies have shown that ruxolitinib cream has significant effects on immune-mediated skin diseases such as atopic dermatitis, especially in relieving patients' symptoms such as itching, redness, and dry skin. According to relevant clinical trial data, patients who use ruxolitinib cream can usually see significant improvement in the lesion area after 4 to 8 weeks of treatment, and skin inflammation and allergic reactions are gradually controlled. In addition, the side effects of ruxolitinib cream are mild. Common adverse reactions when applied topically include skin irritation, dryness or burning sensation, which can usually be alleviated by adjusting the frequency of medication or reducing the amount of ointment used.

Reference: https://www.opzelura.com/